Similar articles

• [Hemodynamic effects of sodium nitroprusside in the absence of coronary insufficiency].

  Mérillon JP, Motte G, Leclerc JF, Fruchaud J, Gourgon R. Mérillon JP, et al. Ann Med Interne (Paris). 1977 Jun-Jul;128(6-7):631-4. Ann Med Interne (Paris). 1977. PMID: 921123 French. No abstract available.
• [Hemodynamic and electrophysiological effects of sodium nitroprusside in patients with acute myocardial infarction].

  Bellotti G, Pileggi F, Galiano N, Camargo PR, Ramires JA, Checchi E, Ping WC, Tranchesi J, Décourt LV. Bellotti G, et al. Arq Bras Cardiol. 1978 Dec;31(6):359-67. Arq Bras Cardiol. 1978. PMID: 751600 Portuguese. No abstract available.
• [Continuous flow vasodilator perfusion treatment in the acute phase of myocardial infarct].

  Prasquier R, Fruchaud J, Gourgon R. Prasquier R, et al. Anesth Analg (Paris). 1977 Nov-Dec;34(6):1281-5. Anesth Analg (Paris). 1977. PMID: 613879 French. No abstract available.
• [Sodium nitroprusside: mechanism of action and clinical application].

  Leshchinskiĭ PM, Mareev VIu. Leshchinskiĭ PM, et al. Ter Arkh. 1982;54(5):148-53. Ter Arkh. 1982. PMID: 6285537 Review. Russian. No abstract available.
• Dobutamine in heart failure.

  Chatterjee K, Bendersky R, Parmley WW. Chatterjee K, et al. Eur Heart J. 1982 Dec;3 Suppl D:107-14. Eur Heart J. 1982. PMID: 6761125 Review. No abstract available.